Troriluzole Hydrochloride acts as a prodrug of riluzole and is an investigational agent currently under study for the treatment of various neurodegenerative and psychiatric disorders, including obsessive-compulsive… Read more
Troriluzole Hydrochloride acts as a prodrug of riluzole and is an investigational agent currently under study for the treatment of various neurodegenerative and psychiatric disorders, including obsessive-compulsive and anxiety conditions. It functions by modulating glutamate neurotransmission to offer potential neuroprotective effects. Analytical laboratories require high-quality reference standards, pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds to support rigorous quality control and method validation protocols for this pharmaceutical substance. By utilizing these precise analytical tools, researchers can ensure accurate impurity profiling and quantitation throughout drug development and stability testing. This category provides the essential materials needed to characterize the chemical profile of this investigational agent, facilitating the development of reliable testing procedures to meet strict regulatory and analytical standards during clinical investigation.